SCHEMBL4867628

SCHEMBL4867628

N#Cc1cc(Cl)cnc1SCCN1CCN(c2cc(Cl)cc3c2OCCN3)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.35
HTR1A P08908 3/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HTR2A P28223 2/20 0.33
HTR7 P34969 1/20 0.32
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31
PARP1 P09874 1/20 0.31
TNK2 Q07912 1/20 0.31
TNK1 Q13470 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
PSMD14 O00487 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
HPGD P15428 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4873454 0.89 DRD2 (0.42) DRD2HTR1ATP53ALOX15TSHR
SCHEMBL4874799 0.85 TP53 (0.36) DRD2HTR1ATP53ALOX15TSHR
SCHEMBL4868226 0.85 HSD17B10 (0.37) DRD2HTR1ATP53ALOX15TSHR
SCHEMBL4877180 0.84 HTR1A (0.38) DRD2HTR1ATP53ALOX15TSHR
SCHEMBL4868483 0.81 ALDH1A1 (0.45) TP53ALOX15TSHRHSD17B10MEN1
SCHEMBL4873209 0.81 KMT2A (0.39) DRD2HTR1ATP53ALOX15TSHR
SCHEMBL4876785 0.81 ALDH1A1 (0.45) DRD2HTR1ATP53ALOX15TSHR
SCHEMBL4868294 0.81 THRB (0.39) DRD2HTR1ATP53ALOX15TSHR
SCHEMBL4872342 0.75 HTR1A (0.41) DRD2HTR1AHTR2AHTR7ADRA1A
SCHEMBL4864840 0.71 HTR1A (0.41) DRD2HTR1ATP53ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7393845-B2 Heteroaryl derivates, their preparation and use H. LUNDBECK A/S (DK) 2008-07-01 US claimed
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2008-01-31 US claimed
EP-1399438-B1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE LUNDBECK & CO AS H (DK) 2005-12-07 EP claimed
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2004-12-09 US claimed
EP-1399438-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. Lundbeck A/S (DK) 2004-03-24 EP claimed
WO-2003002556-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. LUNDBECK A/S (DK) 2003-01-09 WO claimed
US-7393845-B2 Heteroaryl derivates, their preparation and use H. LUNDBECK A/S (DK) 2008-07-01 US disclosed
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2008-01-31 US disclosed
EP-1399438-B1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE LUNDBECK & CO AS H (DK) 2005-12-07 EP disclosed
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use H. LUNDBECK A/S (DK) 2004-12-09 US disclosed
EP-1399438-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. Lundbeck A/S (DK) 2004-03-24 EP disclosed
WO-2003002556-A1 NOVEL HETEROARYL DERIVATIVES, THEIR PREPARATION AND USE H. LUNDBECK A/S (DK) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248883-A1 Novel heteroaryl derivatives, their preparation and use GRIN2C, GRIN2B, HTR1A DRD2 20/4885HTR1A 3/4885TP53 4867/4885
US-20080027071-A1 Novel heteroaryl derivatives, their preparation and use GRIN2C, GRIN2B, HTR2C DRD2 23/4885HTR1A 28/4885TP53 4867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.